Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Fever Labs, founded in 2014 and headquartered in New York, is a global live-entertainment discovery platform that has revolutionized the events and entertainment industry. With a user base of over 125 million people, Fever leverages proprietary technology to offer personalized and curated experiences, connecting event creators with local communities.
The company has shown impressive growth since its inception, attracting significant investment from notable venture capital firms. Fever's most recent funding round, a Series F in January 2023, raised approximately $120 million, valuing the company at $1.96 billion. This substantial valuation increase from its previous round demonstrates strong investor confidence in Fever's business model and growth potential.
While there is no official news regarding Fever Labs' IPO prospects, the company's rapid expansion and substantial funding rounds have naturally led to speculation about its future plans. However, it's important to note that any discussions about a potential IPO remain purely speculative at this time.
Several factors could influence Fever's decision regarding a potential public offering. These include market conditions, the company's financial performance, and its long-term strategic goals. Fever's strong position in the entertainment discovery space, coupled with its impressive user base and valuation, suggests that the company may be well-positioned for future growth opportunities. However, the timing and likelihood of an IPO remain uncertain, and investors should rely on official announcements from the company for accurate information.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Fever Labs' IPO prospects remain uncertain, investors eager to gain exposure to innovative event discovery platforms don't have to wait. At Linqto, we offer members access to interests in pre-IPO private companies, including potential leaders in the entertainment and technology sectors. Our platform allows you to diversify your portfolio with lower minimum investments in promising companies like Fever Labs, potentially benefiting from their growth before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
